Literature DB >> 33452949

Hip fracture and mortality: study of specific causes of death and risk factors.

Montserrat Barceló1, Olga Herminia Torres2, Jordi Mascaró2, Jordi Casademont3.   

Abstract

The leading causes of mortality in our study were pneumonia, diseases of the circulatory system, and dementias. In patients with hip fractures, the emphasis should be placed not only on measures to prevent falls and osteoporosis, but also on preventing functional decline and pneumonia.
PURPOSE: To describe the specific causes of death in patients who died up to 2 years after sustaining a hip fracture, how many of those deaths were directly related to the hip fracture, and the risk factors for mortality.
METHODS: A retrospective review of the clinical data of all patients admitted with hip fractures between December 2009 and September 2015. Cause of death was classified according to the International Statistical Classification of Diseases and Related Health Problems (ICD10)
RESULTS: In the first 2 years after hip fracture, 911 patients (32.7%) died. The leading causes of mortality were pneumonia 177 (19.4%), diseases of the circulatory system 146 (16%), and dementias 126 (13.9%). Thirty patients (3.2%) died from causes directly related to hip fracture or surgery. Mortality risk factors with a higher relative risk were advanced age, male sex, higher comorbidity, delirium, and medical complications during admission.
CONCLUSIONS: Pneumonia and circulatory system diseases were the commonest causes of death in our study. In patients with hip fractures, emphasis should be placed on preventing functional decline and pneumonia. In a few patients, death was directly related to the hip fracture, although decompensation of chronic illness as a result of hip fracture and fracture-related functional decline may have been indirect causes. Patients with worse conditions at admission had the highest risk of mortality.

Entities:  

Keywords:  Cause of death; Hip fracture; Mortality; Mortality risk factors

Mesh:

Year:  2021        PMID: 33452949     DOI: 10.1007/s11657-020-00873-7

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  15 in total

Review 1.  Recent Updates of the Diagnosis and Prevention of Venous Thromboembolism in Patients with a Hip Fracture.

Authors:  Won Chul Shin; Sang Min Lee; Kuen Tak Suh
Journal:  Hip Pelvis       Date:  2017-09-06

2.  Cause of death and factors associated with early in-hospital mortality after hip fracture.

Authors:  B D Chatterton; T S Moores; S Ahmad; A Cattell; P J Roberts
Journal:  Bone Joint J       Date:  2015-02       Impact factor: 5.082

3.  Factors associated with mortality following hip fracture in Japan.

Authors:  Shigeyuki Muraki; Seizo Yamamoto; Hideaki Ishibashi; Kozo Nakamura
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

4.  Insulin-induced cytoplasmic alkalinization and glucose transport in muscle cells.

Authors:  A Klip; T Ramlal; E J Cragoe
Journal:  Am J Physiol       Date:  1986-05

5.  Death after proximal femoral fracture--an autopsy study.

Authors:  J V Perez; D J Warwick; C P Case; G C Bannister
Journal:  Injury       Date:  1995-05       Impact factor: 2.586

Review 6.  [Update of pneumonia in the elderly].

Authors:  Olga H Torres; Eva Gil; Cristina Pacho; Domingo Ruiz
Journal:  Rev Esp Geriatr Gerontol       Date:  2013-01-18

7.  Gender differences in mortality after hip fracture: the role of infection.

Authors:  Lois E Wehren; William G Hawkes; Denise L Orwig; J Richard Hebel; Sheryl I Zimmerman; Jay Magaziner
Journal:  J Bone Miner Res       Date:  2003-12       Impact factor: 6.741

8.  The 1-year mortality of patients treated in a hip fracture program for elders.

Authors:  Scott Schnell; Susan M Friedman; Daniel A Mendelson; Karilee W Bingham; Stephen L Kates
Journal:  Geriatr Orthop Surg Rehabil       Date:  2010-09

9.  Reduction in the incidence of pneumonia in elderly patients after hip fracture surgery: An inpatient pulmonary rehabilitation program.

Authors:  Shih-Chieh Chang; Jiun-I Lai; Mei-Chin Lu; Kuan-Hung Lin; Wei-Shu Wang; Su-Shun Lo; Yi-Chun Lai
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

10.  Symptomatic venous thromboembolism following a hip fracture.

Authors:  Iain McNamara; Aman Sharma; Teresa Prevost; Martyn Parker
Journal:  Acta Orthop       Date:  2009-12       Impact factor: 3.717

View more
  6 in total

1.  Efficiently stratifying mid-term death risk in femoral fractures in the elderly: introducing the ASAgeCoGeCC Score.

Authors:  C Trevisan; G Gallinari; A Carbone; R Klumpp
Journal:  Osteoporos Int       Date:  2021-04-03       Impact factor: 4.507

Review 2.  What do hip fracture patients die from?

Authors:  Spyridon Katsanos; Spyridon Sioutis; Lampros Reppas; Evanthia Mitsiokapa; Aikaterini Tsatsaragkou; Dimitrios Mastrokalos; Dimitrios Koulalis; Andreas F Mavrogenis
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-03-24

3.  Determinants of Higher Mortality at Six Months in Patients with Hip Fracture: A Retrospective Study.

Authors:  Enrique González-Marcos; Enrique González-García; Paula Rodríguez-Fernández; Esteban Sánchez-González; Jerónimo J González-Bernal; Josefa González-Santos
Journal:  J Clin Med       Date:  2022-04-29       Impact factor: 4.964

4.  Identification of risk factors for 1-year mortality among critically ill older adults with hip fractures surgery: A single medical center retrospective study.

Authors:  Taijun Luo; Juxia Zhang; Haibin Zhou; Tao Xu; Wenchao Zhang; Geng Wang
Journal:  Front Surg       Date:  2022-08-31

5.  Effect of Home-based Telerehabilitation on the Postoperative Rehabilitation Outcome of Hip Fracture in the Aging Population.

Authors:  Yuan-Yuan Zhang; Yin-Guang Zhang; Zhen Li; Shi-Hao Li; Wei-Guo Xu
Journal:  Orthop Surg       Date:  2022-07-12       Impact factor: 2.279

6.  Effect of Dementia on Postoperative Mortality in Elderly Patients with Hip Fracture.

Authors:  Yong-Chan Ha; Yonghan Cha; Jun-Il Yoo; Jiyoon Lee; Young-Kyun Lee; Kyung-Hoi Koo
Journal:  J Korean Med Sci       Date:  2021-10-04       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.